A new insulin-enhancing agent: [N,N &prime;-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity

doi:10.1016/j.ejmech.2010.02.010

IR@PKUHSC > 北京大学药学院 > 化学生物学系

学科主题	药学
	A new insulin-enhancing agent: [N,N ′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity
	Xie, Ming-jin 1; Li, Ling 2; Yang, Xiao-Da 3; Liu, Wei-ping 4; Yan, Shi-ping 5; Niu, Yan-fen 2; Meng, Zhao-hui 6
关键词	Insulin-enhancing Salen-type Ligands Caco-2 Cells
刊名	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
	2010-06-01
DOI	10.1016/j.ejmech.2010.02.010
卷	45 期:6 页:2327-2335
收录类别	SCI ; IC
文章类型	Article
WOS标题词	Science & Technology
类目[WOS]	Chemistry, Medicinal
研究领域[WOS]	Pharmacology & Pharmacy
关键词[WOS]	DEPENDENT DIABETES-MELLITUS ; VANADIUM COMPOUNDS ; CRYSTAL-STRUCTURE ; GLUCOSE-HOMEOSTASIS ; MIMETIC AGENT ; IN-VIVO ; RATS ; COMPLEXES ; SULFATE ; BIS(MALTOLATO)OXOVANADIUM(IV)
英文摘要	A new insulin-enhancing agent: [N,N′-bis(4-hydroxysalicylidene)-o-phenylene-diamine] oxovanadium (IV) (BPOV) was synthesized and characterized by X-ray crystallography. BPOV was administered intragastrically to STZ-diabetic rats for 4 weeks. The results showed that BPOV could significantly decrease the blood glucose level and ameliorated impaired glucose tolerance in STZ-diabetic rats. BPOV has been further tested on insulin, glycogen and serum lipid studies. The results suggested BPOV has glucose-lowering activity in diabetic rats, as well as improved the disorder of lipid metabolism in diabetes. BPOV had permeability above 10(-5) cm s(-1). It was suggested good lipophilic properties. The cytotoxicity of BPOV on Caco-2 cells was measured by MTT assay which suggested BPOV have higher effect on impairment of cellular associated with lower level capacity of cellular accumulation.
语种	英语
WOS记录号	WOS:000278056000028
项目编号	30260118 ; 2002C0019R ; 2009CD006 ; 2005Q002A
资助机构	National Natural Science Foundation of China ; Yunnan Natural Science Foundation ; Yunnan University Science Foundation
引用统计	被引频次：13[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.bjmu.edu.cn/handle/400002259/51144
专题	北京大学药学院_化学生物学系
作者单位	1.Yunnan Univ, Dept Chem, Kunming 650091, Yunnan, Peoples R China 2.Kunming Inst Precious Met, Kunming 650221, Peoples R China 3.Nankai Univ, Dept Chem, Tianjin 300071, Peoples R China 4.Kunming Hosp Populat & Hlth, Kunming 650204, Peoples R China 5.Kunming Med Coll, Yunnan Pharmacol Labs Nat Prod, Kunming 650031, Peoples R China 6.Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, Beijing 100083, Peoples R China
推荐引用方式 GB/T 7714	Xie, Ming-jin,Li, Ling,Yang, Xiao-Da,et al. A new insulin-enhancing agent: [N,N ′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2010,45(6):2327-2335.
APA	Xie, Ming-jin.,Li, Ling.,Yang, Xiao-Da.,Liu, Wei-ping.,Yan, Shi-ping.,...&Meng, Zhao-hui.(2010).A new insulin-enhancing agent: [N,N ′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,45(6),2327-2335.
MLA	Xie, Ming-jin,et al."A new insulin-enhancing agent: [N,N ′-bis(4-hydroxysalicylidene)-o-phenylene-diamine]oxovanadium(IV) and its permeability and cytotoxicity".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 45.6(2010):2327-2335.